Eurofins BioPharma Services Newsletter 34 - Febbraio 2023
Eurofins presenta la nuova edizione della newsletter BioPharma NEWS.
ARTICOLI CONTENUTI:
- TruGraf Liver, the first and only gene expression diagnostic that helps optimise immunosuppression treatment for liver transplant patients
- TEM is the ideal complement to in-vitro assays and molecular techniques in determining the microbiological safety of biological products
- Ensuring consumer safety and regulatory compliance for OTC drugs, cosmetic products, and dietary supplements
- Eurofins Discovery helps researchers understand human toxicities related to PFAS
- Celebrating 35 years of Testing for Life – 35 YEARS OF EUROFINS
- Eurofins BioPharma Product Testing offers comprehensive testing services to qualify filters for sterile drug manufacturing
Download PDF Pharma newsletter N°34
- Scarica le edizioni precedenti della nostra newsletter.
Cordiali saluti
Il comitato editoriale del gruppo Eurofins.